Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

445836

	registered interest
	date	19/01/2016
	answering body	Department for Business, Innovation and Skills
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Department for Business, Innovation and Skills: Meetings
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Innovation and Skills, how many meetings Ministers have had with representatives of Keep me Posted since May 2015.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	23120
	answer	answer is ministerial correction date of answer 08/02/2016 answer text <p>Details of Ministers’ meetings with external organisations are published quarterly on the Gov.uk website:</p><p> </p><p><a href="https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data" target="_blank">https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data</a></p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 08/02/2016 15:46:29 answering member 4020 label Biography information for George Freeman
	tabling member	4034 label Biography information for Yvonne Fovargue

1176151

	registered interest
	date	04/02/2020
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Trains: Hydrogen
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, what steps he is taking to transition the self-powered train fleet from diesel to hydrogen.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	12312
	answer	answer is ministerial correction date of answer 11/02/2020 answer text <p>The Government supports the use of hydrogen trains on the railway where appropriate to deliver our legally binding target to reach net-zero greenhouse gas emissions from the UK by 2050.</p><p> </p><p>Network Rail is developing a Traction Decarbonisation Network Strategy which will examine which parts of the network are best suited to use of hydrogen trains, as well as battery and electrification. This will inform Government decisions in 2020.</p><p> </p><p>Our innovation programmes have supported the development of hydrogen technology, such as the ‘Hydroflex’ train, and continue to provide funding opportunities for innovative environmental projects. The Government is also funding work on safety and wider issues that will have to be considered to allow the smooth entry into service on the network of hydrogen trains.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/02/2020 17:22:01 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

147553

	registered interest
	date	10/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure routine access to tamoxifen and raloxifene for the indication of chemoprevention in the UK.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	213936
	answer	answer is ministerial correction date of answer 19/11/2014 answer text <p>In June 2013 the National Institute for Health and Care Excellence (NICE) issued an updated clinical guideline on familial breast cancer which includes recommendations on the use of tamoxifen and raloxifene outside their licensed indications for the prevention of cancer in specific groups of women at high and moderate risk of breast cancer.</p><p> </p><p> </p><p> </p><p>NICE’s clinical guidelines represent best practice and we expect commissioners to take their recommendations into account when designing services and making commissioning decisions for their healthcare population.</p><p> </p><p><strong> </strong></p><p> </p><p>Information on the number of women treated with tamoxifen and raloxifene for the treatment or prevention of breast cancer is not collected centrally.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 213934 question first answered 19/11/2014 15:55:55 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

147554

	registered interest
	date	10/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what proportion of women who are eligible for tamoxifen and raloxifene are offered this treatment.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	213934
	answer	answer is ministerial correction date of answer 19/11/2014 answer text <p>In June 2013 the National Institute for Health and Care Excellence (NICE) issued an updated clinical guideline on familial breast cancer which includes recommendations on the use of tamoxifen and raloxifene outside their licensed indications for the prevention of cancer in specific groups of women at high and moderate risk of breast cancer.</p><p> </p><p> </p><p> </p><p>NICE’s clinical guidelines represent best practice and we expect commissioners to take their recommendations into account when designing services and making commissioning decisions for their healthcare population.</p><p> </p><p><strong> </strong></p><p> </p><p>Information on the number of women treated with tamoxifen and raloxifene for the treatment or prevention of breast cancer is not collected centrally.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 213936 question first answered 19/11/2014 15:55:55 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

147559

	registered interest
	date	10/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to ensure that clinically-proven, cost-effective drugs are made routinely available to all when they are shown to be of use in a new indication but are off-patent.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	214030
	answer	answer is ministerial correction date of answer 19/11/2014 answer text <p>We support appropriate use of off-patent medicines in areas where the evidence suggests that they can deliver patient benefit. Doctors can already prescribe a drug outside its licensed indications where they judge it to be the most clinically appropriate treatment for an individual patient. Medicines are routinely prescribed legally, safely and appropriately outside their licensed indications to large numbers of National Health Service patients.</p><p> </p><p> </p><p> </p><p>We are in the process of setting up a round-table discussion with key stakeholders, NHS England and the National Institute for Health and Care Excellence to review the evidence and explore opportunities to work together to better support appropriate use of these medicines.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 19/11/2014 16:02:12 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

155393

	registered interest
	date	11/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pregnancy Tests
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when the Independent Panel on Hormone Pregnancy Tests will be set up; and what time frame he has set for that inquiry.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	214308
	answer	answer is ministerial correction date of answer 21/11/2014 answer text <p>Membership of the Group is currently being convened and will be finalised in December 2014. The time frame for the inquiry has yet to be finalised but the Panel is expected to review the evidence in the early months of 2015.</p><p> </p><p> </p><p> </p><p>Members of the Expert Working Group on Hormone Pregnancy Tests will be expected to declare any interests (financial or non-financial) in the pharmaceutical industry or in any other area that could affect their impartiality. All members’ interests will be carefully considered in advance and assessed when deciding on the appropriate level of participation in discussions.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 214307 question first answered 21/11/2014 14:26:47 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

155394

	registered interest
	date	11/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pregnancy Tests
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent steps he has taken to ensure the impartiality and neutrality of members of the panel on hormone pregnancy tests.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	214307
	answer	answer is ministerial correction date of answer 21/11/2014 answer text <p>Membership of the Group is currently being convened and will be finalised in December 2014. The time frame for the inquiry has yet to be finalised but the Panel is expected to review the evidence in the early months of 2015.</p><p> </p><p> </p><p> </p><p>Members of the Expert Working Group on Hormone Pregnancy Tests will be expected to declare any interests (financial or non-financial) in the pharmaceutical industry or in any other area that could affect their impartiality. All members’ interests will be carefully considered in advance and assessed when deciding on the appropriate level of participation in discussions.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 214308 question first answered 21/11/2014 14:26:46 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

156915

	registered interest
	date	20/11/2014
	answering body	Department for Business, Innovation and Skills
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Bayer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Innovation and Skills, what meetings (a) he and (b) officials in his Department have had with Bayer plc in the last five years.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	215405
	answer	answer is ministerial correction date of answer 25/11/2014 answer text <p>Details of Ministers’ meetings with external organisations are published quarterly on the Gov.uk website:</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data" target="_blank">https://www.gov.uk/government/publications?departments%5B%5D=department-for-business-innovation-skills&amp;publication_type=transparency-data</a></p><p> </p><p> </p><p> </p><p>Information for April – June 2014 is due to be published soon.</p><p> </p><p>Details of meetings with officials are not held centrally and could only be provided at disproportionate cost.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 25/11/2014 13:46:31 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

169524

	registered interest
	date	10/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Thyroid Gland: Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will commission research on the potential effectiveness of liothyronine (T3) and natural desiccated thyroid for patients with hypothyroidism.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	218084
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) South West Peninsula has partly supported a review of treatment for primary hypothyroidism published in 2012 in the journal <em>Drug Design, Development and Therapy</em>. The review considered approaches including triiodothyronine (liothyronine) therapy, trioodothyronine-levothyroxine combination therapy, and the use of natural desiccated thyroid.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2014 17:22:03 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi

169540

	registered interest
	date	10/12/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anaemia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will commission research on the potential for cost savings and reductions in hospital admissions from improved diagnosis and management of anaemia.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	218235
	answer	answer is ministerial correction date of answer 15/12/2014 answer text <p>The Department has no plans to commission research on this specific topic.</p><p> </p><p> </p><p> </p><p>The Department’s National Institute for Health Research funds a wide range of research relating to the diagnosis and management of different types of anaemia.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2014 17:24:01 answering member 4020 label Biography information for George Freeman
	tabling member	3924 label Biography information for Yasmin Qureshi